Table 5 Comparison of the prevalence of the most common inherited thrombophilia mutations among healthy Palestinian women (healthy controls) observed in this study to that reported by previous Palestinian studies, neighboring Arab countries, and other regions of the world
| Â | Â | Palestinian studies | Neighboring Arab countries | Regions of the world | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Mutation | This study | Ref. [6] | Ref. [32] | Ref. [33] | Lebanon Ref. [24] | Jordan Ref. [42] | Syria Ref. [43] | Egypt Ref. [44] | Europe Ref. [45] | America Ref. [45] |
FVL R506Q | 18 | 18.2 | 23.6 | 20.1 | 9.0 | 30 | 11.5 | 58.1 | 5–9 | 3-5.2 |
FII G20210A | 3 | 4.2 | 5.9 | 9.3 | 2.0 | 8.3 | 2.5 | 4.7 | 2–6 | NA |
MTHFR C677T | 53 | NA | 50.9 | 13.8 | 63.0 | 28.3 | 37.7 | 58.2 | 10–16 | NA |
MTHFR A1298C | 47 | NA | 49.0 | NA | NA | 58.2 | 38.8 | NA | NA | NA |